KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Payables (2016 - 2025)

Labcorp Holdings' Payables history spans 17 years, with the latest figure at $840.8 million for Q4 2025.

  • For Q4 2025, Payables fell 4.0% year-over-year to $840.8 million; the TTM value through Dec 2025 reached $840.8 million, down 4.0%, while the annual FY2025 figure was $840.8 million, 4.0% down from the prior year.
  • Payables for Q4 2025 was $840.8 million at Labcorp Holdings, up from $668.5 million in the prior quarter.
  • Across five years, Payables topped out at $2.8 billion in Q2 2024 and bottomed at $601.7 million in Q2 2021.
  • The 5-year median for Payables is $858.3 million (2024), against an average of $1.2 billion.
  • The largest annual shift saw Payables skyrocketed 174.04% in 2024 before it plummeted 73.77% in 2025.
  • A 5-year view of Payables shows it stood at $622.8 million in 2021, then surged by 85.21% to $1.2 billion in 2022, then skyrocketed by 58.41% to $1.8 billion in 2023, then crashed by 52.07% to $875.8 million in 2024, then dropped by 4.0% to $840.8 million in 2025.
  • Per Business Quant, the three most recent readings for LH's Payables are $840.8 million (Q4 2025), $668.5 million (Q3 2025), and $793.0 million (Q2 2025).